scholarly journals Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy

2020 ◽  
Vol 34 (6) ◽  
pp. 1286-1292 ◽  
Author(s):  
B. Nothegger ◽  
N. Reider ◽  
C.E. Covaciu ◽  
V. Cova ◽  
L. Ahammer ◽  
...  
Keyword(s):  
Specific Immunotherapy ◽  
Birch Pollen ◽  
Pollen Allergy ◽  
Allergen Specific Immunotherapy ◽  
Promising Tool ◽  
Birch Pollen Allergy

scholarly journals ЕФЕКТИВНІСТЬ СУБЛІНГВАЛЬНОЇ АЛЕРГЕН- СПЕЦИФІЧНОЇ ІМУНОТЕРАПІЇ У ДІТЕЙ З ВЕСНЯНИМ ПОЛІНОЗОМ ТА ПИЛКОВО- ХАРЧОВИМ СИНДРОМОМ

World Science ◽  
2019 ◽  
Vol 2 (3(43)) ◽  
pp. 34-41
Author(s):  
С. Ю. Матвєєва ◽  
Т. Р. Уманець
Keyword(s):  
Specific Immunotherapy ◽  
Birch Pollen ◽  
Pollen Allergy ◽  
Allergen Specific Immunotherapy ◽  
Component Resolved Diagnosis ◽  
Birch Pollen Allergy

The article presents the results of the study on the effectiveness and safety of sublingual allergen-specific immunotherapy in children at the age from 4 to 17 years old with spring polinosis and birch-pollen allergy syndrome, which were assessed using visual analogue and combination scales, provocative tests and the results of component resolved diagnosis.

scholarly journals Pollen allergy and household budget

2011 ◽  
Vol 8 (4) ◽  
pp. 79-83
Author(s):  
M A Mokronosova ◽  
M A Mokronosova
Keyword(s):  
Quality Of Life ◽  
Allergic Rhinitis ◽  
Specific Immunotherapy ◽  
Birch Pollen ◽  
Pollen Allergy ◽  
Direct Costs ◽  
Middle Part ◽  
Allergen Specific Immunotherapy ◽  
Severity Of The Disease

The prevalence of the allergy to birch pollen is high in the middle part of russian Federation. the symptoms of allergic intermittent rhinitis appears in the first decade and lasted during all life. the severity of the disease is aggravated annually. the economic burden of allergic rhinitis includes direct, indirect and hidden costs. the indirect cost (disability and loss of productivity, hypoallergenic life arrangements) exceeds direct costs many times. allergen specific immunotherapy by pollen allergovaccines is unique kind of pathogenic management. asIt demonstrates significant improvement of the symptoms of rhinitis and asthma, quality of life. one of the main problems is high costs of asIt. economical models used in investigations on asIt cost effectiveness demonstrated lucre in the following 10 years of life after 3 year's course of asIt. In order to achieve high clinical result it is necessary to follow european standard's guidance on specific immunotherapy strictly.

scholarly journals Birch pollen allergy in Europe

Allergy ◽  
2019 ◽  
Author(s):  
T. Biedermann ◽  
L. Winther ◽  
S. J. Till ◽  
P. Panzner ◽  
A. Knulst ◽  
...  
Keyword(s):  
Birch Pollen ◽  
Pollen Allergy ◽  
Birch Pollen Allergy

scholarly journals COMPARATIVE CHARACTERISTICS OF SAFETY OF SUBLINGUAL AND PARENTERAL IMMUNOTHERAPY METHODS

2020 ◽  
Vol 17 (34) ◽  
pp. 736-744
Author(s):  
Ulbossyn SALTABAYEVA ◽  
Alexei YUMASHEV
Keyword(s):  
Adverse Reactions ◽  
Specific Immunotherapy ◽  
Sublingual Immunotherapy ◽  
Scientific Evidence ◽  
Adult Population ◽  
Pollen Allergy ◽  
Hay Fever ◽  
Sharp Drop ◽  
Allergen Specific Immunotherapy ◽  
Good Substitute

Among a significant number of allergies, the most common among children and adults is pollen allergy. Pollen allergies primarily lead to irritation of the nose and eyes, but can also cause headaches, weakness, fatigue, and decreased attention span. In an acute allergic reaction, anaphylactic shock can occur, that is, a lifethreatening sharp drop in blood pressure. These and many other consequences of allergic reactions imply the need to create drugs that could cure a person of allergies or stop the manifestation of allergen reactions. The aim of the article was to study the safety of allergen-specific immunotherapy. The research methods included an analysis of the comparison of the effectiveness of two immunotherapy methods, a comparison of the safety of sublingual and parenteral methods of administering allergic vaccines, a comparative assessment of the safety of types of allergen-specific immunotherapy. The study involved 228 patients with varying severity of hay fever, among whom were children from 5 to 18 years old and an adult population (113 patients were men, 115 were women). The study revealed that sublingual immunotherapy increases the safety of treatment and is a good substitute for parenteral immunotherapy, especially in children. The studies have also confirmed well-known scientific evidence on the safety of sublingual immunotherapy in patients with hay fever. It was concluded that sublingual immunotherapy increases the safety of treatment and is a good substitute for the parenteral allergenspecific immunotherapy method, especially in pediatric patients, while having several advantages, such as a significant reduction in adverse reactions, high potency, and a convenient mode of administration, greater patient commitment and trust in treatment, and the elimination of infection transmission.

scholarly journals Patching it together: epicutaneous vaccination with heat-labileEscherichia colitoxin against birch pollen allergy

Allergy ◽  
2016 ◽  
Vol 72 (1) ◽  
pp. 5-8 ◽  
Author(s):  
S. S. Killingbeck ◽  
M. Q. Ge ◽  
A. Haczku
Keyword(s):  
Birch Pollen ◽  
Pollen Allergy ◽  
Birch Pollen Allergy
Sign in / Sign up

Export Citation Format

Share Document